These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19333202)

  • 1. Kinetics and prognostic value of inflammatory-sensitive protein, IL-6, and white blood cell levels in patients undergoing coronary stent implantation.
    Ziakas A; Gavrilidis S; Giannoglou G; Souliou E; Koskinas K; Gemitzis K; Hatzimiltiadis S; Efthimiadis G; Paraskevaidis S; Hatzitolios A; Savopoulos C; Parharidis G
    Med Sci Monit; 2009 Apr; 15(4):CR177-84. PubMed ID: 19333202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
    Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
    Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris.
    Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P
    Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina.
    Ziakas A; Gavrilidis S; Souliou E; Giannoglou G; Stiliadis I; Karvounis H; Efthimiadis G; Mochlas S; Vayona MA; Hatzitolios A; Savopoulos C; Pidonia I; Parharidis G
    Angiology; 2009; 60(1):50-9. PubMed ID: 18388036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting.
    Guler N; Batyraliev T; Dulger H; Ozkara C; Tuncer M; Aslan S; Okut H; Agirbasli M
    Int J Cardiol; 2006 May; 109(3):339-43. PubMed ID: 16040142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting.
    Patti G; Di Sciascio G; D'Ambrosio A; Dicuonzo G; Abbate A; Dobrina A
    Catheter Cardiovasc Interv; 2002 Jul; 56(3):341-5. PubMed ID: 12112886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different patterns of interleukin-6 and von Willebrand factor antigen changes after coronary stenting in unstable versus stable angina.
    Spaziani D; De Servi S; Morelli B; D'Urbano M; Vandoni P; Mariani G; Passoni F; Cafiero F
    Ital Heart J; 2002 Oct; 3(10):593-7. PubMed ID: 12478817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?
    Hedman A; Larsson PT; Alam M; Wallen NH; Nordlander R; Samad BA
    Int J Cardiol; 2007 Aug; 120(1):108-14. PubMed ID: 17141340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
    Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
    Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of systematic biological markers of inflammation for the prognosis at 12 months of patients undergoing programmed coronary angioplasty].
    Donal E; Nanadoumgar H; Ragot S; Lecron JC; Mauco G; Allal J; Herpin D
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):101-7. PubMed ID: 15787300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory response after dexamethasone eluting coronary stent implantation.
    Mut-Vitcu B; Drăgulescu SI; Drăgulescu A; El Kahlout A; Coroban A; Maximov D; Slovenski M
    Rom J Intern Med; 2004; 42(1):119-27. PubMed ID: 15529601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal stenosis.
    Li JJ; Fang CH; Jiang H; Huang CX; Hui RT; Chen MZ
    Clin Chim Acta; 2004 Dec; 350(1-2):115-21. PubMed ID: 15530467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammatory and fibrinolytic activation after coronary artery bypass with extracorporeal circulation].
    Gaudino M; Nasso G; Zamparelli R; Andreotti F; Burzotta F; Iacoviello L; Santarelli F; Lapenna E; Bruno P; Di Pietrantonio F; Schiavello R; Maseri A; Possati G
    Ital Heart J Suppl; 2002 Jun; 3(6):646-51. PubMed ID: 12116815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.
    Rebeiz AG; Zoghbi E; Harb R; Youhanna S; Skouri HN; Dimassi A; Abou-Nader G; Nasrallah A; Sawaya J; Gharzuddine W; Alam S
    J Interv Cardiol; 2009 Apr; 22(2):169-74. PubMed ID: 19245380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina.
    Li JJ; Zhang YP; Yang P; Zeng HS; Qian XW; Zhang CY; Zhu CG; Li J; Nan JL
    Coron Artery Dis; 2008 Aug; 19(5):293-7. PubMed ID: 18607165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting.
    Inoue T; Kato T; Uchida T; Sakuma M; Nakajima A; Shibazaki M; Imoto Y; Saito M; Hashimoto S; Hikichi Y; Node K
    J Am Coll Cardiol; 2005 Jul; 46(2):239-45. PubMed ID: 16022949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preprocedural C-reactive protein levels predict myocardial necrosis after successful coronary stenting in patients with stable angina.
    Goldberg A; Gruberg L; Roguin A; Petcherski S; Rimer D; Markiewicz W; Beyar R; Aronson D
    Am Heart J; 2006 Jun; 151(6):1265-70. PubMed ID: 16781234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting.
    Paiva MS; Serrano CV; Nicolau JC; Jalbut BO; Fernandes JL; De Lemos JA; Blotta MH; De Oliveira RT; De Oliveira IR; De Oliveira Lda A; Ramires JA
    J Interv Cardiol; 2008 Oct; 21(5):403-9. PubMed ID: 18705636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White blood cell count, leucocyte elastase activity, and serum concentrations of interleukin-6 and C-reactive protein after open appendicectomy.
    Eriksson S; Olander B; Pira U; Granström L
    Eur J Surg; 1997 Feb; 163(2):123-7. PubMed ID: 9076439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.